Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2015-06-19

FDA Approved: CLINDAMYCIN PHOSPHATE AND BENZOYL PEROXIDE — Original Application (Actavis Pharma, Inc.)

View source ↗

Summary

FDA approved the original application for a topical acne product containing clindamycin phosphate and benzoyl peroxide, manufactured by Actavis Pharma, Inc.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Clindamycin Phosphate and Benzoyl Peroxide (clindamycin phosphate and benzoyl peroxide)

Snippet

ORIG AP for CLINDAMYCIN PHOSPHATE AND BENZOYL PEROXIDE (CLINDAMYCIN PHOSPHATE AND BENZOYL PEROXIDE)